Journal

Tandem's broader clinical platform creates real competitive pressure. Specialist tools need depth, direct clinician value and evidence of continued usefulness, not comforting categ...

A shared clinical AI interface can contain functions with different purposes and risks. Tandem's expanding suite shows why product boundaries and change control matter.

Ask Tandem now competes beyond consultation notes. Compare contextual answers with editorial depth, source navigation, independent reference and active clinical learning.

A startup ranking is not a clinical benchmark. Here is how doctors and procurement teams can evaluate Tandem and other AI tools against the tasks that actually matter.

Tandem's integrations reveal a competition over clinical distribution. Connection depth, maintenance, partner dependence and exit arrangements matter more than logo counts.

Tandem's ambition extends beyond documentation. What it would take to coordinate clinical work reliably, and where specialist tools could remain important.

Four different routes to medical information: encounter context, research access, curated knowledge and reference-linked learning. What clinicians should compare.

Tandem leads Sifted's 2026 startup ranking. What that reveals about vertical AI businesses, and what it does not establish about clinical performance.

Clinical AI value can come from evidence, workflow and implementation rather than model ownership alone. What Tandem and specialist platforms reveal about the opportunity.

Separate clinical applications, cloud operation and model development when assessing European healthcare AI, with Tandem, Scaleway and Mistral as distinct examples.

Read Tandem's 44-model, 50-transcript benchmark correctly: clinical-claim accuracy, selected omissions, clinician preference and the limits of a displayed 100.0% score.

What Tandem Sovereign Health changes about infrastructure and model operation, who can request it, and what a healthcare organisation should establish before migrating.